Balloon Valvuloplasty Device Market Growth To $3.35 Billion By 2030: What’s Driving The Expansion?
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Balloon Valvuloplasty Device Market Value Growth And Long-Term Outlook
The balloon valvuloplasty device market size has observed substantial growth in recent years. It is projected to expand from $2.57 billion in 2025 to $2.73 billion in 2026, at a compound annual growth rate (CAGR) of 5.9%. Historically, this expansion can be attributed to a rise in the prevalence of cardiac valve stenosis, the early adoption of minimally invasive interventional cardiology procedures, the development of standard and compliant balloon technologies, the expansion of hospital-based cardiac catheterization labs, and increasing treatment volumes in pediatric congenital heart cases.
The balloon valvuloplasty device market is anticipated to experience substantial growth over the coming years. By 2030, its value is projected to reach $3.35 billion, demonstrating a compound annual growth rate (CAGR) of 5.3%. This expansion during the forecast period can be attributed to an aging population increasingly affected by aortic and mitral valve stenosis, a rising demand for high-pressure and scoring balloon devices, the broader application of balloon valvuloplasty in ambulatory and specialty clinics, a growing shift towards non-surgical cardiac treatment options, and ongoing innovations in balloon materials and device design. Significant trends expected during this period include a growing preference for minimally invasive valve repair procedures, the increasing adoption of balloon valvuloplasty as an alternative to open-heart surgery, its expanded use in pediatric and adult congenital heart valve disorders, the proliferation of valve dilation procedures in specialized cardiology centers, and a concentrated effort on improving patient outcomes and shortening recovery times.
Get A Free Sample Report With In-Depth Market Insights:
Balloon Valvuloplasty Device Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The increasing preference for minimally invasive procedures is anticipated to fuel the expansion of the balloon valvuloplasty device market in the coming years. These medical techniques involve making small incisions or utilizing natural body openings, leading to reduced patient trauma and quicker recovery periods compared to conventional surgical methods. The escalating demand for minimally invasive procedures stems from their benefits, which include shorter recovery durations, a reduced likelihood of complications, and less post-operative discomfort when contrasted with traditional surgeries. Balloon valvuloplasty devices are employed in minimally invasive surgical interventions to enlarge constricted heart valves, enhance blood circulation, and alleviate associated symptoms. An illustrative example of this trend is seen in January 2024, when Intuitive Surgical Inc., a US-based producer of robotic healthcare equipment, announced the deployment of 415 da Vinci surgical systems (robotic systems utilizing a minimally invasive approach) during the fourth quarter of 2023, marking a 12% increase over 2022. Consequently, the growing adoption of minimally invasive procedures is a key factor propelling the development of the balloon valvuloplasty device market.
Balloon Valvuloplasty Device Market Segment Analysis Spotlighting Growth Areas
The balloon valvuloplasty device market covered in this report is segmented –
1) By Product Type: Standard Balloon, Cutting Balloon, Scoring Balloon, High-Pressure Balloon, Low-Pressure Balloon
2) By Age Group: Pediatric, Adult
3) By End-use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
Subsegments:
1) By Standard Balloon: Non-Compliant Balloons, Compliant Balloons
2) By Cutting Balloon: Single-Cutting Balloon, Multi-Cutting Balloon
3) By Scoring Balloon: Single-Score Balloons, Dual-Score Balloons
4) By High-Pressure Balloon: Non-Compliant High-Pressure Balloons, Compliant High-Pressure Balloons
5) By Low-Pressure Balloon: Semi-Compliant Low-Pressure Balloons, Non-Compliant Low-Pressure Balloons
Balloon Valvuloplasty Device Market Innovation Trends Shaping Future Development
Leading companies operating in the balloon valvuloplasty device market are concentrating on developing advanced offerings, such as Pacing Guidewires, to gain a competitive edge. A pacing guidewire is a specialized instrument utilized to deliver temporary cardiac pacing during the procedure, guaranteeing the heart maintains a stable rhythm while the balloon catheter is inserted and inflated to dilate the narrowed valve. For instance, in June 2023, Teleflex Incorporated, a US-based medical device company, received clearance from the Food and Drug Administration (FDA) for the Wattson Temporary Pacing Guidewire. This novel device is specifically designed for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV) procedures. The Wattson Temporary Pacing Guidewire offers dual functionality, supporting both valve delivery and ventricular bipolar pacing during these structural heart procedures. Its flexible distal pigtail shape, multiple electrodes, and bipolar design are engineered to help reduce the risk of ventricular perforation while providing reliable electrical capture during rapid pacing.
Balloon Valvuloplasty Device Market Competitive Overview And Top Companies
Major companies operating in the balloon valvuloplasty device market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Edwards Lifesciences Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical Incorporated, Balton Sp z o o, Meril Life Sciences Pvt Ltd, JenaValve Technology Inc, Osypka Medical GmbH, Scitech Medical, Translumina GmbH, AndraTec GmbH, Palex Medical SA, Biosensors International Group Ltd, Hexacath, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, QT Vascular Ltd
View The Full Balloon Valvuloplasty Device Market Report:
Balloon Valvuloplasty Device Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the balloon valvuloplasty device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon valvuloplasty device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
